Статья
Комплексная гериатрическая оценка у пациентов пожилого и старческого возраста с сердечно-сосудистыми заболеваниями. Экспертное мнение Российской Ассоциации Геронтологов и Гериатров
Синдром старческой астении (ССА) – это гериатрический синдром, характеризующийся возраст-ассоциированным снижением физиологического резерва и функций многих систем организма, приводящий к повышенной уязвимости организма пожилого человека к воздействию эндо- и экзогенных факторов с высоким риском развития неблагоприятных исходов для здоровья, потери автономности и смерти. Наиболее часто ССА встречается у коморбидных пожилых пациентов. При сердечно-сосудистых заболеваниях ССА ассоциирован с худшим прогнозом: бóльшей частотой развития обострений и высоким уровнем смертности как во время острых событий, так и при хроническом течении заболевания. Однако при создании диагностического и терапевтического плана ведения пожилых пациентов с сердечно-сосудистыми заболеваниями (ССЗ) ССА часто не учитывается. В данной статье мы проанализируем имеющиеся научные данные о ССА, алгоритме его диагностики и рассмотрим шкалы, которые могут быть полезны для формирования индивидуального плана ведения пожилых пациентов с ССЗ.
1. Singh M, Stewart R, White H. Importance of frailty in patients with cardiovascular disease. European Heart Journal. 2014;35(26):1726–31. DOI: 10.1093/eurheartj/ehu197
2. Rich MW, Chyun DA, Skolnick AH, Alexander KP, Forman DE, Kitzman DW et al. Knowledge Gaps in Cardiovascular Care of the Older Adult Population. Journal of the American College of Cardiology. 2016;67(20):2419–40. DOI: 10.1016/j.jacc.2016.03.004
3. Rodríguez-Mañas L, Féart C, Mann G, Viña J, Chatterji S, Chodzko-Zajko W et al. Searching for an Operational Definition of Frailty: A Delphi Method Based Consensus Statement. The Frailty Operative Definition-Consensus Conference Project. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2013;68(1):62–7. DOI: 10.1093/gerona/gls119
4. Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J. Prevalence of Frailty in Middle-Aged and Older Community-Dwelling Europeans Living in 10 Countries. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2009;64(6):675–81. DOI: 10.1093/gerona/glp012
5. Newman AB, Gottdiener JS, Mcburnie MA, Hirsch CH, Kop WJ, Tracy R et al. Associations of subclinical cardiovascular disease with frailty. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2001;56(3):M158-166. DOI: 10.1093/gerona/56.3.m158
6. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The Lancet. 2013;381(9868):752–62. DOI: 10.1016/S0140-6736(12)62167-9
7. Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, Hébert R et al. Prevalence, Attributes, and Outcomes of Fitness and Frailty in Community-Dwelling Older Adults: Report from the Canadian Study of Health and Aging. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2004;59(12):1310–7. DOI: 10.1093/gerona/59.12.1310
8. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al. Frailty in Older Adults: Evidence for a Phenotype. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2001;56(3):M146–57. DOI: 10.1093/gerona/56.3.M146
9. Sourial N, Bergman H, Karunananthan S, Wolfson C, Payette H, Gutierrez-Robledo LM et al. Implementing Frailty Into Clinical Practice: A Cautionary Tale. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2013;68(12):1505–11. DOI: 10.1093/gerona/glt053
10. Ткачева О.Н., Котовская Ю.В., Рунихина Н.К., Фролова Е.В., Наумов А.В., Воробьева Н.М. и др. Клинические рекомендации «Старческая астения». Российский журнал гериатрической медицины. 2020; 1:11-46. DOI: 10.37586/2686-8636-1-2020-11-46
11. Ткачева О.Н., Котовская Ю.В., Рунихина Н.К., Фролова Е.В., Наумов А.В., Воробьева Н.М. и др. Клинические рекомендации «Старческая астения». Часть 2. Российский журнал гериатрической медицины. 2020; 2:115-30. DOI: 10.37586/2686-8636-2-2020-115-130
12. Pilotto A, Ferrucci L, Franceschi M, D’Ambrosio LP, Scarcelli C, Cascavilla L et al. Development and Validation of a Multidimensional Prognostic Index for One-Year Mortality from Comprehensive Geriatric Assessment in Hospitalized Older Patients. Rejuvenation Research. 2008;11(1):151–61. DOI: 10.1089/rej.2007.0569
13. Rolfson DB, Majumdar SR, Taher A, Tsuyuki RT. Development and validation of a new instrument for frailty. Clinical and Investigative Medicine. Medecine Clinique Et Experimentale. 2000; 23:28–30.
14. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age and Ageing. 2006;35(5):526–9. DOI: 10.1093/ageing/afl041
15. McCusker J, Bellavance F, Cardin S, Trepanier S, Verdon J, Ardman O. Detection of Older People at Increased Risk of Adverse Health Outcomes After an Emergency Visit: The ISAR Screening Tool. Journal of the American Geriatrics Society. 1999;47(10):1229–37. DOI: 10.1111/j.1532-5415.1999.tb05204.x
16. Walker D, Gale C, Lip G, Martin-Sanchez F, McIntyre H, Mueller C et al. Editor’s Choice - Frailty and the management of patients with acute cardiovascular disease: A position paper from the Acute Cardiovascular Care Association. European Heart Journal: Acute Cardiovascular Care. 2018;7(2):176–93. DOI: 10.1177/2048872618758931
17. Heckman GA, McKelvie RS, Rockwood K. Individualizing the care of older heart failure patients. Current Opinion in Cardiology. 2018;33(2):208–16. DOI: 10.1097/HCO.0000000000000489
18. Фомин И.В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский Кардиологический Журнал. 2016; 8:7-13. DOI: 10.15829/1560-4071-2016-8-7-13
19. Mitnitski A, Howlett SE, Rockwood K. Heterogeneity of Human Aging and Its Assessment. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 2016;72(7):877–84. DOI: 10.1093/gerona/glw089
20. Foebel AD, Hirdes JP, Heckman GA, Tyas SL, Tjam EY. A profile of older community-dwelling home care clients with heart failure in Ontario. Chronic Diseases in Canada. 2011;31(2):49–57. PMID: 21466754
21. Dodson JA, Truong T-TN, Towle VR, Kerins G, Chaudhry SI. Cognitive Impairment in Older Adults with Heart Failure: Prevalence, Documentation, and Impact on Outcomes. The American Journal of Medicine. 2013;126(2):120–6. DOI: 10.1016/j.amjmed.2012.05.029
22. Díez-Villanueva P, Ariza-Solé A, López J, García-Pardo H, Martín-Sánchez FJ, Martínez-Sellés M. Selección de lo mejor del año 2017 en insuficiencia cardiaca del paciente anciano. Revista Española de Cardiología. 2018;71(2):120–1. DOI: 10.1016/j.recesp.2017.10.002
23. Chaudhry SI, McAvay G, Chen S, Whitson H, Newman AB, Krumholz HM et al. Risk Factors for Hospital Admission Among Older Persons with Newly Diagnosed Heart Failure. Journal of the American College of Cardiology. 2013;61(6):635–42. DOI: 10.1016/j.jacc.2012.11.027
24. Uchmanowicz I, Łoboz-Rudnicka M, Szeląg P, Jankowska-Polańska B, Łoboz-Grudzień K. Frailty in Heart Failure. Current Heart Failure Reports. 2014;11(3):266–73. DOI: 10.1007/s11897-014-0198-4
25. Jha SR, Hannu MK, Newton PJ, Wilhelm K, Hayward CS, Jabbour A et al. Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation. Transplantation Direct. 2017;3(7):e167. DOI: 10.1097/TXD.0000000000000690
26. Chiarantini D, Volpato S, Sioulis F, Bartalucci F, Del Bianco L, Mangani I et al. Lower Extremity Performance Measures Predict LongTerm Prognosis in Older Patients Hospitalized for Heart Failure. Journal of Cardiac Failure. 2010;16(5):390–5. DOI: 10.1016/j.cardfail.2010.01.004
27. Vidán MT, Sánchez E, Fernández-Avilés F, Serra-Rexach JA, Ortiz J, Bueno H. FRAIL-HF, a Study to Evaluate the Clinical Complexity of Heart Failure in Nondependent Older Patients: Rationale, Methods and Baseline Characteristics. Clinical Cardiology. 2014;37(12):725–32. DOI: 10.1002/clc.22345
28. Vidán MT, Blaya-Novakova V, Sánchez E, Ortiz J, Serra-Rexach JA, Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. European Journal of Heart Failure. 2016;18(7):869–75. DOI: 10.1002/ejhf.518
29. Sutton JL, Gould RL, Daley S, Coulson MC, Ward EV, Butler AM et al. Psychometric properties of multicomponent tools designed to assess frailty in older adults: A systematic review. BMC Geriatrics. 2016;16(1):55. DOI: 10.1186/s12877-016-0225-2
30. Martín-Sánchez FJ, Christ M, Miró Ò, Peacock WF, McMurray JJ, Bueno H et al. Practical approach on frail older patients attended for acute heart failure. International Journal of Cardiology. 2016; 222:62–71. DOI: 10.1016/j.ijcard.2016.07.151
31. Ekerstad N, Swahn E, Janzon M, Alfredsson J, Löfmark R, Lindenberger M et al. Frailty Is Independently Associated with Short-Term Outcomes for Elderly Patients with Non–ST-Segment Elevation Myocardial Infarction. Circulation. 2011;124(22):2397–404. DOI: 10.1161/CIRCULATIONAHA.111.025452
32. Murali-Krishnan R, Iqbal J, Rowe R, Hatem E, Parviz Y, Richardson J et al. Impact of frailty on outcomes after percutaneous coronary intervention: a prospective cohort study. Open Heart. 2015;2(1): e000294. DOI: 10.1136/openhrt-2015-000294
33. Pilotto A, Addante F, Franceschi M, Leandro G, Rengo G, D’Ambrosio P et al. Multidimensional Prognostic Index Based on a Comprehensive Geriatric Assessment Predicts Short-Term Mortality in Older Patients with Heart Failure. Circulation: Heart Failure. 2010;3(1):14–20. DOI: 10.1161/CIRCHEARTFAILURE.109.865022
34. Tegn N, Abdelnoor M, Aaberge L, Endresen K, Smith P, Aakhus S et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. The Lancet. 2016;387(10023):1057–65. DOI: 10.1016/S0140-6736(15)01166-6
35. Alonso Salinas GL, Sanmartín Fernández M, Pascual Izco M, Marco del Castillo Á, Rincón Díaz LM, Lozano Granero C et al. Frailty predicts major bleeding within 30 days in elderly patients with Acute Coronary Syndrome. International Journal of Cardiology. 2016; 222:590–3. DOI: 10.1016/j.ijcard.2016.07.268
36. Alonso Salinas GL, Sanmartín Fernández M, Pascual Izco M, Martín Asenjo R, Recio-Mayoral A, Salvador Ramos L et al. Frailty is a short-term prognostic marker in acute coronary syndrome of elderly patients. European Heart Journal: Acute Cardiovascular Care. 2016;5(5):434–40. DOI: 10.1177/2048872616644909
37. White HD, Westerhout CM, Alexander KP, Roe MT, Winters KJ, Cyr DD et al. Frailty is associated with worse outcomes in non-STsegment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. European Heart Journal: Acute Cardiovascular Care. 2016;5(3):231–42. DOI: 10.1177/2048872615581502
38. Sanchis J, Bonanad C, Ruiz V, Fernández J, García-Blas S, Mainar L et al. Frailty and other geriatric conditions for risk stratification of older patients with acute coronary syndrome. American Heart Journal. 2014;168(5):784-791.e2. DOI: 10.1016/j.ahj.2014.07.022
39. Sanchis J, Ruiz V, Bonanad C, Valero E, Ruescas-Nicolau MA, Ezzatvar Y et al. Prognostic Value of Geriatric Conditions Beyond Age After Acute Coronary Syndrome. Mayo Clinic Proceedings. 2017;92(6):934–9. DOI: 10.1016/j.mayocp.2017.01.018
40. Matsuzawa Y, Konishi M, Akiyama E, Suzuki H, Nakayama N, Kiyokuni M et al. Association Between Gait Speed as a Measure of Frailty and Risk of Cardiovascular Events After Myocardial Infarction. Journal of the American College of Cardiology. 2013;61(19):1964–72. DOI: 10.1016/j.jacc.2013.02.020
41. Huded CP, Huded JM, Friedman JL, Benck LR, Lindquist LA, Holly TA et al. Frailty Status and Outcomes After Transcatheter Aortic Valve Implantation. The American Journal of Cardiology. 2016;117(12):1966–71. DOI: 10.1016/j.amjcard.2016.03.044
42. Kleczynski P, Dziewierz A, Bagienski M, Rzeszutko L, Sorysz D, Trebacz J et al. Impact of frailty on mortality after transcatheter aortic valve implantation. American Heart Journal. 2017; 185:52–8. DOI: 10.1016/j.ahj.2016.12.005
43. Afilalo J, Lauck S, Kim DH, Lefèvre T, Piazza N, Lachapelle K et al. Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study. Journal of the American College of Cardiology. 2017;70(6):689–700. DOI: 10.1016/j.jacc.2017.06.024
44. Green P, Arnold SV, Cohen DJ, Kirtane AJ, Kodali SK, Brown DL et al. Relation of Frailty to Outcomes After Transcatheter Aortic Valve Replacement (from the PARTNER Trial). The American Journal of Cardiology. 2015;116(2):264–9. DOI: 10.1016/j.amjcard.2015.03.061
45. Fukui S, Kawakami M, Otaka Y, Ishikawa A, Mizuno K, Tsuji T et al. Physical frailty in older people with severe aortic stenosis. Aging Clinical and Experimental Research. 2016;28(6):1081–7. DOI: 10.1007/s40520-015-0507-0
46. Alfredsson J, Stebbins A, Brennan JM, Matsouaka R, Afilalo J, Peterson ED et al. Gait Speed Predicts 30-Day Mortality after Transcatheter Aortic Valve Replacement: Results from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation. 2016;133(14):1351–9. DOI: 10.1161/CIRCULATIONAHA.115.020279
47. Bernal E, Ariza-Solé A, Bayés-Genís A, Formiga F, Díez-Villanueva P, Romaguera R et al. Management of Nonagenarian Patients with Severe Aortic Stenosis: The Role of Comorbidity. Heart, Lung and Circulation. 2018;27(2):219–26. DOI: 10.1016/j.hlc.2017.02.033
48. Martínez-Sellés M, Díez-Villanueva P, Sánchez-Sendin D, Carro Hevia A, Gómez Doblas JJ, García de la Villa B et al. Comorbidity and intervention in octogenarians with severe symptomatic aortic stenosis. International Journal of Cardiology. 2015; 189:61–6. DOI: 10.1016/j.ijcard.2015.04.017
49. Maddox TM, Januzzi JL, Allen LA, Breathett K, Butler J, Davis LL et al. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2021;77(6):772–810. DOI: 10.1016/j.jacc.2020.11.022
50. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. EP Europace. 2021; euab065.. DOI: 10.1093/europace/euab065